management for transient ischemic attack(TIA)
Secondary prevention of future stroke includes antiplatelet agents (eg, aspirin, clopidogrel) to prevent thrombus formation and ☆statin therapy (HMG-CoA reductase inhibitor; eg, atorvastatin, rosuvastatin) to reduce atherosclerotic plaque formation. Lifestyle modifications (eg, exercise, tobacco cessation) are also recommended.
neurology
UWorld
dominant hemisphere and dominant hand
99% of the right handed→dominant hemisphere is on the left
neurology
rehabilitation
complete paralysis
anal sensation,motor
neurology
small cell carcinoma
ACTH→Cushing syndrome
endocrinology
respiratory
neurology
normal intracranial calcification
pineal gland, habenula(手綱), choroid plexus, basal ganglia, dentate nuclei
neurology
pilocytic astrocytoma
(Juvenile) pilocytic astrocytomas usually arise in the ☆cerebellum, brainstem, hypothalamic region, or optic pathways.
neurology
neurosurgery
UWorld
PRL産生腫瘍か非機能性腺腫か
下垂体腺腫の治療の第一選択は，PRL産生下垂体腺腫は薬物療法（ドパミン作動薬：ブロモクリプチン，テルグリド，カベルゴリン），その他の腫瘍（GH産生下垂体腺腫，非機能性下垂体腺腫など）では手術である．一般的にプロラクチン産生下垂体腺腫のプロラクチン値は200ng/mL以上となる（実際には数千もの高値をとることもある）．PRL 34.8ng/mLが下垂体茎圧迫による軽度上昇の範囲
neurology
neurosurgery
国試
Klüver-Barrera染色
髄鞘（ミエリン）を青く染色するので，大脳白質は青，皮質と基底核の青みは弱い（髄鞘が少ないため）．矢印の部位は大脳の内部にあるので基底核（尾状核，被殻，淡蒼球）に含まれ，側脳室に面しているので尾状核
neurology
国試
mutation in spinal and bulbar muscular atrophy
SBMA
neurology
国試
女性のDuchenne型筋ジストロフィー症
●Lyon現象
neurology
国試
CAG triplet diseases
Spinal and bulbar muscular atrophy (SBMA)
neurology
国試
近位筋萎縮の例外
spinal muscular atrophy (SMA)
neurology
国試
medic media模試
early and late onset of Alzheimer's disease
eary→ associated with Amyloid precursor protein(APP) (on chromosome 21)
neurology
genetics
UWorld
medications which have agonism and antagonism at the opioid receptors
☆nalbuphine, pentazocine
pharmacology
neurology
